Provider P34-19 Change to Prior Authorization Requirements for Outpatient Therapies and Chiropractic Services for Commercial and Medicare Products Read More
Provider P26R1-19 Update: New Medical, Medical Drug and Behavioral Health Policy Management Updates for Commercial & Medicare Advantage Lines of Business – Effective May 6, 2019 Read More
Provider P36-19 Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Utilization Management Program Read More
Provider P38-19 Change to Outpatient Therapies Prior Authorization Requirements for Medicare Advantage Subscribers Read More
Provider P33-19 New Medical, Medical Drug and Behavioral Health Policy Management Updates for Commercial & Medicare Advantage Lines of Business Read More
Provider QP30-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Hereditary transthyretin-mediated (hATTR) Amyloidosis Neuropathy Read More
Provider QP32-19 Pharmacy Benefit Exclusion for Glyrx-PF, Libtayo, Lumoxiti, Onpattro, Poteligeo, and Xerava Read More
